Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Compared To Glatiramer Acetate And Fingolimod For The Treatment Of Relapsing-Remitting Multiple Sclerosis
Abstract
Authors
J.A. Mauskopf M. Fay R. Iyer T. Livingston
J.A. Mauskopf M. Fay R. Iyer T. Livingston
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now